ES2112747A1 - Formulaciones farmaceuticas solidas orales para un carbonato basico de aluminio y magnesio con una disponibilidad palatabilidad mejorada. - Google Patents

Formulaciones farmaceuticas solidas orales para un carbonato basico de aluminio y magnesio con una disponibilidad palatabilidad mejorada.

Info

Publication number
ES2112747A1
ES2112747A1 ES09500049A ES9500049A ES2112747A1 ES 2112747 A1 ES2112747 A1 ES 2112747A1 ES 09500049 A ES09500049 A ES 09500049A ES 9500049 A ES9500049 A ES 9500049A ES 2112747 A1 ES2112747 A1 ES 2112747A1
Authority
ES
Spain
Prior art keywords
magnesium carbonate
pharmaceutical formulations
palatability
basic aluminium
solid oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09500049A
Other languages
English (en)
Other versions
ES2112747B1 (es
Inventor
Vidal Jose Luis Fabregas
Mauri Jacinto Moragues
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall SA
Original Assignee
Laboratorios Almirall SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Almirall SA filed Critical Laboratorios Almirall SA
Priority to ES9500049A priority Critical patent/ES2112747B1/es
Publication of ES2112747A1 publication Critical patent/ES2112747A1/es
Application granted granted Critical
Publication of ES2112747B1 publication Critical patent/ES2112747B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FORMULACIONES FARMACEUTICAS SOLIDAS PARA ADMINISTRACION POR VIA ORAL DE CARBONATO BASICO DE ALUMINIO Y MAGNESIO, DE FORMULA AL2MG6(OH)14(CO3)2.4H2O, CONOCIDO COMUNMENTE COMO ALMAGATO Y QUE CONTIENEN UN AGENTE AGLUTINANTE HIDROFILICO, UN DESINTEGRANTE INTRAGRANULAR Y UN DESINTEGRANTE INTERGRANULAR JUNTO CON EXCIPIENTES FARMACEUTICAMENTE ACEPTABLES. ESTAS FORMULACIONES SE USAN PARA EL TRATAMIENTO DE TRASTORNOS DEL TRACTO GASTROINTESTINAL, ESPECIALMENTE HIPERACIDEZ GASTRICA.
ES9500049A 1995-01-13 1995-01-13 Formulaciones farmaceuticas solidas orales para un carbonato basico de aluminio y magnesio con una disponibilidad palatabilidad mejorada. Expired - Fee Related ES2112747B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9500049A ES2112747B1 (es) 1995-01-13 1995-01-13 Formulaciones farmaceuticas solidas orales para un carbonato basico de aluminio y magnesio con una disponibilidad palatabilidad mejorada.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9500049A ES2112747B1 (es) 1995-01-13 1995-01-13 Formulaciones farmaceuticas solidas orales para un carbonato basico de aluminio y magnesio con una disponibilidad palatabilidad mejorada.

Publications (2)

Publication Number Publication Date
ES2112747A1 true ES2112747A1 (es) 1998-04-01
ES2112747B1 ES2112747B1 (es) 1999-09-16

Family

ID=8289134

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9500049A Expired - Fee Related ES2112747B1 (es) 1995-01-13 1995-01-13 Formulaciones farmaceuticas solidas orales para un carbonato basico de aluminio y magnesio con una disponibilidad palatabilidad mejorada.

Country Status (1)

Country Link
ES (1) ES2112747B1 (es)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2018952A6 (es) * 1989-10-17 1991-05-16 Walton Sa Procedimiento de preparacion de composiciones antiacidas con tiempo prolongado de permanencia gastrica.
EP0486863A1 (de) * 1990-11-17 1992-05-27 Bayer Ag Antazida-Zubereitung mit verlängerter Magenverweilzeit
WO1992015204A1 (en) * 1991-03-11 1992-09-17 Cima Labs, Inc. Magnesium carbonate and oil tableting aid and flavoring additive

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2018952A6 (es) * 1989-10-17 1991-05-16 Walton Sa Procedimiento de preparacion de composiciones antiacidas con tiempo prolongado de permanencia gastrica.
EP0486863A1 (de) * 1990-11-17 1992-05-27 Bayer Ag Antazida-Zubereitung mit verlängerter Magenverweilzeit
US5213794A (en) * 1990-11-17 1993-05-25 Bayer Aktiengesellschaft Antacid preparation having a prolonged gastric residence time
WO1992015204A1 (en) * 1991-03-11 1992-09-17 Cima Labs, Inc. Magnesium carbonate and oil tableting aid and flavoring additive

Also Published As

Publication number Publication date
ES2112747B1 (es) 1999-09-16

Similar Documents

Publication Publication Date Title
CA2310960A1 (en) Phosphate-binding polymers for oral administration
EP0699072A4 (en) IRON-BINDING POLYMERS FOR ORAL ADMINISTRATION
WO1996039156A3 (en) Phosphate-binding polymers for oral administration
MY125662A (en) Pharmaceutical formulations containing darifenacin
HK1035492A1 (en) Devices for providing prolonged drug therapy.
EP1566174A3 (en) Flash-melt oral dosage formulation
AU2584192A (en) Bone-growth-stimulating composition
CA2259148A1 (en) Solid oral dosage forms of valsartan
CA2360248A1 (en) Combinations of formoterol and a tiotropium salt
CA2131350A1 (en) Sustained release drug formulation containing a tramadol salt
MX9804008A (es) Formulaciones farmaceuticas.
CA2171938A1 (en) Flexible Retainer Flange for Gastrostomy Tube
CA2315261A1 (en) Oral pharmaceutical extended release dosage form
HK1043048A1 (en) Combinations of formoterol and mometasone furoate
CA2111002A1 (en) Non-Chlorofluorocarbon Aerosol Formulations
NZ506188A (en) A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
PL307491A1 (en) Pharmaceutical agents for oral administration
CA2283408A1 (en) Swallow tablet comprising paracetamol
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
WO1992018111A3 (en) Pharmaceutical composition for the treatment of gastritis
IL112745A0 (en) Formulations for orally administered pharmaceutical agents
ES2112747A1 (es) Formulaciones farmaceuticas solidas orales para un carbonato basico de aluminio y magnesio con una disponibilidad palatabilidad mejorada.
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
CA2370501A1 (en) Pharmaceutical composition for the therapy of lower urinary tract symptoms
GB2134783A (en) Medical preparation having antitumoral effect

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19980401

Kind code of ref document: A1

Effective date: 19980401

PC2A Transfer of patent
FD2A Announcement of lapse in spain

Effective date: 20110223